Natural Product (NP) Details
General Information of the NP (ID: NP0812) | |||||
---|---|---|---|---|---|
Name |
Oleanolic acid
|
||||
Synonyms |
OLEANOLIC ACID; 508-02-1; Oleanic acid; Caryophyllin; Astrantiagenin C; Giganteumgenin C; Virgaureagenin B; 3beta-Hydroxyolean-12-en-28-oic acid; 3-beta-Hydroxyolean-12-en-28-oic acid; UNII-6SMK8R7TGJ; (3-beta)-3-Hydroxyolean-12-en-28-oic acid; MFCD00064914; NSC114945; 6SMK8R7TGJ; (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; NSC-114945; CHEBI:37659; oleonolic acid; Oleanolic acid, 97%; NSC 114945; Olean-12-en-28-oic acid, 3-hydroxy-, (3beta)-; (2S,5S,10S,18S,1R,14R,15R,20R)-18-hydroxy-1,2,8,8,15,19,19-heptamethylpentacyc lo[12.8.0.0<2,11>.0<5,10>.0<15,20>]docos-11-ene-5-carboxylic acid; (4aS,5S,6aS,6bR,8R,8aR,10S,12aR,12bR,14bS)-10-Hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-2H-picene-4a-carboxylic acid; 3-Beta-Hydroxy-Olean-12-En-28-Oicaci; SMR000445561; CCRIS 6493; OLEANOLIC_ACID; CHEMBL168; EINECS 208-081-6; oleanolic acids; oleanolic-acid; OleanolsA currencyure; Oleanoic Acid Hydrate; Olean-12-en-28-oic acid, 3.beta.-hydroxy-; Oleanolic acid anhydrous; Oleanolic acid, >=97%; SCHEMBL71070; MLS000697656; MLS002207133; Olean-12-en-28-oic acid, 3-hydroxy-, (3-beta)-; GTPL3306; AOB5588; DTXSID50858790; HMS2232D15; Oleanolic acid (OA)(Compound 1); Oleanolic acid, analytical standard; EX-A1991; HY-N0156; ZINC3785416; BDBM50346601; 3-beta-Hydroxyolean-12-en-28-oate; 3beta-hydroxy-Olean-12-en-28-oate; AKOS015951416; AC-8026; CCG-208530; CS-3800; LMPR0106150004; VA11435; 3.beta.-hydroxy-Olean-12-en-28-oate; 3 -hydroxy-Olean-12-en-28-oic acid; 3beta-hydroxy-Olean-12-en-28-oic acid; (4aS,6aS,6bR,8aR,10S,12aR,12bR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydropicene-4a(2H)-carboxylic acid; AS-35338; BP-25410; ST057162; (3-beta)-3-Hydroxyolean-12-en-28-oate; (3?)-3-Hydroxyolean-12-en-28-oic acid; 3.beta.-hydroxy-Olean-12-en-28-oic acid; N1826; (3.beta.)-3-hydroxy-Olean-12-en-28-oate; C17148; (3.beta.)-3-hydroxy-Olean-12-en-28-oic acid; (3.beta.)-3-beta-hydroxy-Olean-12-en-28-oate; 508O021; Q418628; Olean-12-en-28-oic acid, 3-beta-hydroxy- (8CI); Olean-12-en-28-oic acid, 3beta-hydroxy- (8CI); Q-100572; (3.beta.)-3-beta-hydroxy-Olean-12-en-28-oic acid; Oleanolic acid, primary pharmaceutical reference standard; C7EE6ACC-7175-4947-B524-FF8479525DA1; Oleanolic acid, European Pharmacopoeia (EP) Reference Standard; Oleanolic acid, United States Pharmacopeia (USP) Reference Standard
Click to Show/Hide
|
||||
Species Origin | Olea europaea ... | Click to Show/Hide | |||
Olea europaea | |||||
Disease | Breast cancer [ICD-11: 2C60] | Investigative | [1] | ||
Structure |
![]() |
Click to Download Mol2D MOL |
|||
Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
Formula |
C30H48O3
|
||||
PubChem CID | |||||
Canonical SMILES |
CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1)C)C(=O)O)C
|
||||
InChI |
1S/C30H48O3/c1-25(2)14-16-30(24(32)33)17-15-28(6)19(20(30)18-25)8-9-22-27(5)12-11-23(31)26(3,4)21(27)10-13-29(22,28)7/h8,20-23,31H,9-18H2,1-7H3,(H,32,33)/t20-,21-,22+,23-,27-,28+,29+,30-/m0/s1
|
||||
InChIKey |
MIJYXULNPSFWEK-GTOFXWBISA-N
|
||||
CAS Number |
CAS 508-02-1
|
||||
ChEBI ID | |||||
Herb ID | |||||
SymMap ID | |||||
TCMSP ID | |||||
TTD Drug ID |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
Isoniazid + Rifampicin + Ethambutol | Click to Show/Hide the Molecular Data of This Drug | |||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) |
Combination Info
![]() |
|||||
In-vitro Model | Vero | CVCL_0059 | Healthy | Chlorocebus sabaeus | ||
Experimental
Result(s) |
Oleanolic acid and combination displayed either a synergistic interaction or did not show any interaction against two drug-sensitive strains. |
Target and Pathway | ||||
---|---|---|---|---|
Target(s) | Herpes simplex virus DNA polymerase UL30 (HSV UL30) | Molecule Info | [3] | |
Myophosphorylase (PYGM) | Molecule Info | [4] |
